Self-collected samples to test for cervical cancer are a step in the right direction when it comes to addressing healthcare ...
Tylenol and autism, the Inflation Reduction Act, the One Big Beautiful Bill, Most Favored Nation pricing and direct drug ...
Libtayo's approval for high-risk cutaneous squamous cell carcinoma offers a new immunotherapy option, targeting PD-1 ...
Transparency, prior authorization, PBM reform and PBM offered genomics testing are some the trends Formulary Watched tracked ...
The FDA warned against unapproved sunscreen forms, while Australian tests exposed inaccurate SPF claims, causing consumer ...
Renuka Iyer, M.D., will assume the role of CMO at NCCN, focusing on advancing evidence-based cancer care and guideline ...
New drug prices increased by 51% over three years, often exceeding value benchmarks, potentially costing the healthcare system $1.5 billion. Providers worry about medication stocking due to Part B ...
The FDA has approved Jascayd (nerandomilast) as a treatment for a second lung disease, progressive pulmonary fibrosis, following the drug’s initial approval in October 2025 as a treatment for ...
Type 1 diabetes is a disease where the immune system destroys insulin-producing beta cells in pancreatic islets. About 2 million Americans have Type 1 diabetes. The islets of Langerhans are named for ...
Due to eczema, asthma and allergies being so closely connected, coordinated care plays a critical role in long-term outcomes. Allergists are uniquely trained to manage these conditions together rather ...
Vixarelimab, a monoclonal antibody, showed rapid and sustained itch relief in PN, with mild side effects and diverse patient applicability. Soficitinib, an oral TYK2 inhibitor, entered phase 2 trials, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback